<PAGE> 1
FORM 8-K
SECURITIES AND EXCHANGE COMMISSION
Washington, DC 20549
CURRENT REPORT
Pursuant to Section 13 or 15(d) of the Securities
Exchange Act of 1934
Date of Report: September 1, 1997
HESKA CORPORATION
------------------------------------------------------
(Exact name of registrant as specified in its charter)
DELAWARE 000-22427 77-0192527
- ---------------- ------------ --------------
(State or other (Commission (IRS Employer
jurisdiction of File Number) Identification
corporation) No.)
1825 SHARP POINT DRIVE, FORT COLLINS CO 80525
- --------------------------------------- ----------
(Address of principal executive office) (Zip Code)
Registrant's telephone number, including area code:
(970) 493-7272
<PAGE> 2
Item 9. Sales of Equity Securities Pursuant to Regulation S.
On September 1, 1997, in connection with the acquisition of
all of the outstanding shares of capital stock of CMG Centre Medical des
Grands'Places SA ("CMG"), a corporation organized under the laws of
Switzerland, by the registrant, the registrant issued an aggregate of 59,905
shares of its Common Stock to two shareholders of CMG in satisfaction of
approximately $540,000 of the acquisition price. The issued shares were sold
outside the United States to non-U.S. persons (as defined in Regulation S) in
reliance on multiple exemptions from registration, including without limitation
Regulation S under the Securities Act of 1933, as amended.
<PAGE> 3
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934,
the registrant has duly caused this report to be signed on its behalf by the
undersigned hereunto duly authorized.
Dated: September 12, 1997
HESKA CORPORATION
By /s/ WILLIAM G. SKOLOUT
-------------------------------
WILLIAM G. SKOLOUT
Chief Financial Officer
